Results 51 to 60 of about 18,051 (238)

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset

open access: yesNetherlands Heart Journal, 2023
Introduction The MYH7 c.5135G > A p.(Arg1712Gln) variant has been identified in several patients worldwide and is classified as pathogenic in the ClinVar database.
L. Marsili   +40 more
semanticscholar   +1 more source

Novel Mutations in β-MYH7 Gene in Indian Patients With Dilated Cardiomyopathy

open access: yesCJC Open, 2022
Background: Heart failure is a hallmark of severe hypertrophic cardiomyopathy and dilated cardiomyopathy (DCM). Several mutations in the β-MYH7 gene lead to hypertrophic cardiomyopathy.
Deepa Selvi Rani, PhD   +7 more
doaj   +1 more source

Proteomics of Cytochrome c Oxidase-Negative versus -Positive Muscle Fiber Sections in Mitochondrial Myopathy [PDF]

open access: yes, 2019
The mosaic distribution of cytochrome c oxidase(+) (COX+) and COX - muscle fibers in mitochondrial disorders allows the sampling of fibers with compensated and decompensated mitochondrial function from the same individual.
Doll, S.   +5 more
core   +3 more sources

The expression of MYH7 gene in femur, humeral muscle and back muscle tissues of fattening lambs of the Kermani breed [PDF]

open access: yesمجله بیوتکنولوژی کشاورزی, 2023
ObjectiveSkeletal muscles make up about 40% of body weight and are responsible for many functions, such as maintaining required energy, maintaining body condition, and protecting tissues. Normal growth of skeletal muscles is a prerequisite for animals to
Samira Shokri   +3 more
doaj   +1 more source

Atrophy, oxidative switching and ultrastructural defects in skeletal muscle of the ataxia telangiectasia mouse model [PDF]

open access: yes, 2019
Ataxia telangiectasia is a rare, multi system disease caused by ATM kinase deficiency. Atm-knockout mice recapitulate premature aging, immunodeficiency, cancer predisposition, growth retardation and motor defects, but not cerebellar neurodegeneration and
Aguanno, Salvatore   +8 more
core   +1 more source

A bioprinted cardiac patch composed of cardiac-specific extracellular matrix and progenitor cells for heart repair [PDF]

open access: yes, 2018
Congenital heart defects are present in 8 of 1000 newborns and palliative surgical therapy has increased survival. Despite improved outcomes, many children develop reduced cardiac function and heart failure requiring transplantation.
Bejleri, Donald   +6 more
core   +1 more source

Silencing of MYH7 ameliorates disease phenotypes in human iPSC-cardiomyocytes [PDF]

open access: yesPhysiological Genomics, 2020
Allele-specific RNA silencing has been shown to be an effective therapeutic treatment in a number of diseases, including neurodegenerative disorders. Studies of allele-specific silencing in hypertrophic cardiomyopathy (HCM) to date have focused on mouse models of disease. We here examine allele-specific silencing in a human-cell model of HCM.
Alexandra Dainis   +12 more
openaire   +4 more sources

SNPs within the beta myosin heavy chain (MYH7) and the pyruvate kinase muscle (PKM2) genes in horse

open access: yesItalian Journal of Animal Science, 2010
Two highly expressed skeletal muscle genes (the MYH7 gene encoding the myosin heavy chain slow/β-cardiac isoform and the PKM2 gene encoding the pyruvate kinase muscle isoforms) were investigated with the objective to identify DNA markers in horses ...
Vincenzo Russo   +4 more
doaj   +1 more source

Hypertrophic cardiomyopathy MYH7 mutation R723G alters mRNA secondary structure [PDF]

open access: yesPhysiological Genomics, 2020
Point mutation R723G in the MYH7 gene causes hypertrophic cardiomyopathy (HCM). Heterozygous patients with this mutation exhibit a comparable allelic imbalance of the MYH7 gene. On average 67% of the total MYH7 mRNA are derived from the MYH7R723G-allele and 33% from the MYH7WT allele.
J. Rose, T. Kraft, B. Brenner, J. Montag
openaire   +2 more sources

Clinical exome performance for reporting secondary genetic findings. [PDF]

open access: yes, 2014
BACKGROUND : Reporting clinically actionable incidental genetic findings in the course of clinical exome testing is recommended by the American College of Medical Genet- ics and Genomics (ACMG).
Clark, P   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy